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Abstract
Background: The application of antisense molecules, such as morpholino oligonucleotides, is an efficient method
of gene inactivation in vivo. We recently introduced phosphonic ester modified peptide nucleic acids (PNA) for in
vivo loss-of-function experiments in medaka embryos. Here we tested novel modifications of the PNA backbone to
knockdown the medaka tcf3 gene.
Results: A single tcf3 gene exists in the medaka genome and its inactivation strongly affected eye development of
the embryos, leading to size reduction and anophthalmia in severe cases. The function of Tcf3 strongly depends on
co-repressor interactions. We found interactions with Groucho/Tle proteins to be most important for eye
development. Using a dominant negative approach for combined inactivation of all groucho/tle genes also resulted
in eye phenotypes, as did interference with three individual tle genes.
Conclusions: Our results show that side chain modified PNAs come close to the knockdown efficiency of
morpholino oligonucleotides in vivo. A single medaka tcf3 gene combines the function of the two zebrafish
paralogs hdl and tcf3b. In combination with Groucho/Tle corepressor proteins Tcf3 acts in anterior development
and is critical for eye formation.
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Background
Antisense molecules which inhibit mRNA activity through
a Watson-Crick base pair mechanism have been studied for
several decades. Blocker molecules, such as morpholino oli-
gonucleotides and peptide nucleic acids (PNAs), show high
specificity and low toxic effects (reviewed by Summerton
[1]). The morpholino backbone consists of 6-membered
morpholine rings connected by non-ionic phosphorodiami-
date linker-units [2]. In PNAs the phosphate ribose ring of
DNA is replaced with repeating N-[2-aminoethyl]-glycine
(aeg) units linked by amide bonds. This provides a neutral
backbone and results in complementary PNA/DNA strands
having stronger binding affinity than DNA/DNA [3]. In
addition, introduction of mismatches destabilizes the PNA/
DNA duplex more than they do in DNA/DNA. PNAs are
highly stable against enzymatic degradation and changes in
temperature and pH. Moreover, due to their short length
(13-18 bases) the likelihood that secondary structures form
is reduced which results in stable and sequence specific
probes [4–6]. Unmodified aegPNAs, however, show low ef-
ficiency in vivo, therefore, various terminal- and internal
modifications have been tested. For example, the addition
of lysine residues improves their solubility [7]. The
introduction of negative charges in mixed sequence
HypNA-PNAs allowed specific down regulation of target
genes in zebrafish embryos [8]. Recently, pePNAs which
contain phosphonic ester (pe) side chains in an otherwise
non-modified aegPNA backbone were successfully applied
to target six3 in medaka embryos. In particular combined
versions containing both aeg non-modified- and
pe-modified PNA blocks were most effective. In a direct
comparison morpholino oligonucleotides were active at
lower concentrations, but also showed higher toxicity [9].
Tcf/Lef (T-cell factor/lymphoid enhancer factor)
proteins belong to the high mobility group (HMG)
box-containing family of transcription factors [10].
They are the most distal players of the canonical Wnt
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pathway and the main partner for β-catenin in gene regu-
lation [11, 12]. In the absence of Wnt ligands, β-catenin is
degraded in the cytosol and Tcf/Lef interacts with tran-
scriptional co-repressors such as Groucho/Tle (Groucho/
Transducin-like enhancer) and CtBP (C-terminus Binding
Protein), thereby repressing target gene expression [13].
Upon Wnt stimulation, β-catenin is stabilized and translo-
cated into the nucleus. Nuclear accumulation leads to
interaction of β-catenin with Tcf/Lef which promotes
specific gene expression [11].
In non-vertebrates transcriptional activation and re-
pression is regulated solely by a single tcf gene, for ex-
ample pangolin in Drosophila and POP-1 in C. elegans,
whereas vertebrates have four, more specialized and
partly redundant homologues (tcf1, tcf3, tcf4 and lef1)
[11]. While Tcf1 and Tcf4 proteins play a role in both ac-
tivation and repression, Lef1 primarily functions as an
activator [14] and Tcf3 appears to function exclusively as
a repressor [15]. In mice, tcf3 knockout experiments re-
sulted in gastrulation defects that resemble ectopic Wnt
expression such as duplication of the anterior-posterior
(AP) axis. At later stages abundant neuroectodermal
cells and defective neural patterning were observed [16].
In addition, Tcf3 seems to be a regulator of pluripotency.
Embryonic stem (ES) cells show high levels of Tcf3 and
only low Wnt pathway activity, thereby remaining in a
balanced state between pluripotency and differentiation.
When tcf3 is knocked down or Wnt genes are overex-
pressed, the ES cells do not undergo efficient differenti-
ation and the balance is tipped towards pluripotency [17,
18]. In zebrafish two tcf3 genes have been reported,
headless hdl/tcf3 [19] and tcf3b [20], which both act as
repressors. At the shield stage (mid-gastrulation) hdl is
broadly expressed in the epiblast while tcf3b demon-
strates only weak expression, at late gastrulation both
genes are expressed in the rostral neuroectoderm and
later on throughout the brain with a gap of expression
in the mid-hindbrain boundary (MHB) [20]. In hdl mu-
tants the forebrain is lost while the expression of genes
that characterize the MHB is expanded [19]. This
phenotype can be rescued by tcf3b overexpression, indi-
cating redundant functions of hdl and tcf3b [20]. tcf3b
knockdown results in smaller heads but otherwise nor-
mal brain patterning, whereas interference with both
tcf3 genes leads to strong caudalization [20].
One mechanism of Tcf3-mediated repression results
from its interaction with Groucho/Tle proteins [13, 21, 22],
which are transcriptional co-repressors that lack direct
DNA-binding ability. Instead they bind to DNA-bound
proteins and assist in repression (reviewed by Turki-Judeh
and Courey [23]). In the case of Tcf3, Groucho/Tle tetra-
mers bind to an N-terminally located groucho interaction
domain [24]. This interaction is disrupted by the Groucho/
Tle repressor Aes [21], which is a truncated form of
Groucho/Tle consisting only of the N-terminal Q- and GP-
domains [25, 26].
Here we analyzed the function of tcf3 in medaka em-
bryos using both gain- and loss-of-function experiments.
For the knockdown we used pePNAs and morpholino
oligonucleotides. Novel side chain modifications further
improved the activity of the PNAs, resulting in knock-
down efficiencies directly comparable to those of the
morpholino oligonucleotides. Furthermore, we analyzed
the effect of Groucho/Tle proteins on the repressive
function of Tcf3 using a dominant negative approach
and antisense oligonucleotides.
Results
Isolation and expression of the medaka tcf3 gene
We used a BLAST search to identify homologs of the
tcf3 gene in the medaka genome, using the mouse Tcf3
protein sequence as a template. In this work, we identi-
fied several homologs of tcf/lef genes, however, only one
single hit matched the tcf3 gene (corresponding Ensembl
transcript ENSORLT00000014810 located on chromo-
some 9 and encoding for a 600 amino acid protein). The
presence of a single tcf3 gene in medaka was also
reported previously [27]. In order to study the expres-
sion pattern of the medaka tcf3 gene, we isolated a
cDNA fragment by RT-PCR and performed whole
mount in situ hybridization (Fig. 1). During gastrulation,
tcf3 is broadly expressed throughout the embryonic
shield (40% epiboly; Fig. 1a), followed by an anterior shift
towards the prospective head region (Fig. 1c) and into the
embryonic body (Fig. 1b,c) at late gastrula stage. At the
neurula stage the expression becomes restricted to the
head region (Fig. 1d,d’) and appears in posterior regions of
the embryo later during somitogenesis (Fig. 1e-h’). When
the first subdivisions of the brain can be distinguished,
tcf3 expression becomes segmented into the telenceph-
alon, midbrain and hindbrain domains (Fig. 1e,e’). Similar
to the expression of zebrafish tcf3 [20], medaka tcf3 is not
expressed in the MHB (Fig. 1e-g). Furthermore, tcf3 is also
expressed in the eyes and the otic placodes (Fig. 1e).
During somitogenesis, tcf3 expression further extends
caudally (Fig. 1f-h’), where it is then found in the pectoral
fins and the somites in late stages (Fig. 1h, h’). Interest-
ingly, the expression pattern of tcf3 in medaka combines
the expression domains of the zebrafish genes hdl (tcf3a)
and tcf3b [20].
The medaka tcf3 gene is crucial for eye development
In order to understand the function of the medaka tcf3
gene during embryogenesis, we performed knockdown
experiments using PNAs and morpholino oligonucleo-
tides. We used a 16mer mixed pePNA (Fig. 2a) and a
25mer morpholino oligonucleotide sequence directed
against the medaka tcf3 mRNA directly upstream of the
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translation start codon (Fig. 2b). Injection of PNAs and
morpholino oligonucleotides resulted in the same pheno-
types. The embryos progressed through gastrulation with-
out apparent defects; however, eye development was later
specifically impaired (Fig. 3b-d). For phenotype classifica-
tion, we separated the embryos into three groups (weak,
moderate and strong): weak embryos (Fig. 3b,f) exhibited
one or two slightly smaller eyes than the control group,
whereas in embryos with a moderate phenotype the size re-
duction was severe (Fig. 3c,g). Embryos without eyes were
categorized as having a strong phenotype (Fig. 3d,h). Inter-
estingly, in zebrafish the phenotypes for the two tcf3 genes
differ considerably, however, in hdl/tcf3b double morphants
they add up to one combined phenotype representing the
complete absence of Tcf3 proteins [20]. Medaka embryos
with a strong phenotype correspond to this extreme case,
whereas embryos of the weak and moderate groups dem-
onstrate phenotypes in between those for hdl [19] and tcf3b
[20] in zebrafish.
To further characterize the tcf3 loss-of-function
phenotype, we next examined the expression of pax2,
pax6, gbx1 and wnt1 (Fig. 3i-p), which is known to be
affected by Tcf3 activity [20]. In those embryos the ex-
pression domains of all three genes were shifted anteri-
orly (Fig. 3m-o) compared to the wild type control
embryos (Fig. 3i-k). In 48% of the embryos (n = 61) the
expression domain of the forebrain marker pax6 was
smaller (Fig. 3m) and instead of two separate domains
on either side of the prospective head (Fig. 3i), only a
single cap-like structure was observed at the most anter-
ior region of the prospective neural domain (Fig. 3m).
However, we did not see a complete loss of anterior
pax6 expression. The expression of pax2, a marker of
the MHB, was shifted anteriorly in 56% of the
morphants (n = 36), partially overlapping with the pax6
domain (Fig. 3n) which is in good agreement with the
expression pattern found in zebrafish hdl mutants [20].
In 37% of the embryos (n = 43) an altered expression of
the hindbrain marker gbx1 was observed, where again
the entire expression domain was shifted anteriorly
(Fig. 3o). In addition, the lateral edges of less severely
caudalized embryos pointed anteriorly and in more
severe phenotypes, the expression expanded into an
arc-like shape, thereby overlapping with the expression
domains of both pax6 and pax2. We also analysed the
MHB marker wnt1 in tcf3 knockdown embryos and
found expression in a more anterior position (Fig. 3b).
Taken together, the expression of all marker genes
clearly indicates the expected anterior shift for tcf3
inactivation.
Improvement of PNA specificity
Qualification of the pigmented retinal structures of the eyes
allowed a simple but reliable phenotype classification.
Based on these results we could compare the knockdown
efficiency of the different antisense molecules. We first used
a mixed pePNA (Tcf3PNA), which contains two tri-methyl-
lysine (TML) terminal groups. For each concentration the
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Fig. 1 tcf3 expression in medaka embryonic development. Whole
mount in situ hybridization experiments were performed in wild
type embryos at the indicated stages, using a digoxigenin-labelled
RNA probe against tcf3. Embryos are shown in dorsal view, anterior
at the top. (f-h) Flat mounts; (f'-h') tail view. During gastrulation (a-c)
tcf3 is expressed throughout the epiblast and the embryonic body
(c-d). In neurula the expression becomes restricted to the head
(d,d') from where it spreads caudally and divides into a forebrain,
midbrain, and hindbrain section (e;e'). A gap in expression at the
mid-hindbrain boundary (f-h, arrowhead) is closed at later stages (h).
In later stages, expression is observed throughout the entire body
(g-h'). Scale bars 100 μm; a, a-c; f, f-f′; g, g-h′. Abbreviations: st, stage
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number of phenotypes of the different groups was de-
termined and the total number of tcf3 knockdown
phenotypes among the surviving embryos was calcu-
lated (Fig. 4a and Additional file 1). Between 100 μM
and 400 μM of Tcf3PNA the total number of pheno-
types increased from 22% to 51%. At 600 μM and
900 μM the overall frequency of phenotypes (both
57%) and also the number of dead embryos (6% and
7%, respectively) remained unchanged, which indicates
a low toxicity. At 1200 μM the percentage of tcf3-
specific phenotypes increased to 86%, however, the
mortality rate also increased to 38%, indicating ele-
vated toxicity of the PNA at higher concentrations.
As expected, these increasing numbers of phenotypes
also resulted in a continuous shift from preferentially
weak phenotypes at low concentrations to a high pro-
portion of strong phenotypes at high concentrations
(Additional file 1). The morpholino oligonucleotide
showed phenotypes indistinguishable from the pePNAs,
but differed in their efficiency. High rates of tcf3-specific
phenotypes, 71% and 92%, already appeared at low con-
centrations, 50 μM and 100 μM, respectively. However, at
200 μM the mortality rate jumped to 44%, indicating toxic
effects (Fig. 4b and Additional file 1). At concentrations
with high mortality rates, some embryos with unspecific
phenotypes appeared which looked similar for both
pePNAs and morpholino oligonucleotides. We previously
described such unspecifically affected medaka embryos,
which have smaller eyes but show severe defects over the
entire brain [9]. Such unspecific phenotypes were not
detected at non-toxic concentrations. Taken together, the
morpholino oligonucleotide was more efficient than the
pePNA at low concentrations, but also showed higher
toxicity.
Fig. 2 Sequences of medaka tcf3 antisense molecules and their targets. a Schematic chemical structure of aegPNAs, pePNAs. Mixed PNAs contain
C3- (R1) or lysine-phosphonic-ester- (R2) residues. b mRNA targets are shown in the 5′-3′ orientation, capital letters indicate the coding region.
The AUG start codon is underlined. Pre-mRNA represents the unspliced mRNA precursor of the medaka tcf3 gene with exon 1 sequences shown
in capital letters (exon 1 includes the first 62 amino acids of Tcf3). Tcf3MO represents a morpholino oligonucleotide, all other sequences PNAs.
aegPNA components are shown with grey overlay, pePNA components with C3-phosphonic-ester (R1) side chains are shown in red letters, those
with lysine-phosphonic-ester (R2) side chains in red overlay. Boxed bases represent mismatches. All PNA and morpholino oligonucleotides are
shown in 3′-5′ orientation. L represents a trimethyl-lysine and K a dimethyl-lysine
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Thereafter, we tested the pePNAs’ splice blocking
efficiency. A sequence overlapping with both exon 1 and in-
tron 1 was selected and also synthesized as a mixed PNA
with a double TML end group (Tcf3spPNA; Fig. 2b). The
result of this splice block is a truncated and therefore non-
functional protein. Upon PNA injection the same pheno-
types were observed as were found for Tcf3PNA, however,
with lower efficiency (Fig. 4a and Additional file 1). The
highest number of specifically affected embryos (49%) was
observed at a concentration of 900 μM. At 1200 μM
toxicity became dominant, similar to that seen for
Tcf3PNA. We reasoned that a combination of both the
translational blocking and the splice blocking PNAs might
result in an improved knockdown efficiency. Indeed, co-
injection of Tcf3PNA and Tcf3spPNA, each at a concentra-
tion of 200 μM, resulted in 50% of the embryos showing
phenotypes (Fig. 4a and Additional file 1), which is higher
than the percentage of affected embryos for both 400 μM
Tcf3PNA (39%) and 400 μM Tcf3spPNA (30%). Therefore,
the combined injection of both PNAs led to a synergistic
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Fig. 3 Loss of function phenotypes for the tcf3 gene in medaka. Embryos at the 1-cell stage were co-injected with 300 μM morpholino oligonucleotide
(Tcf3MO) and 1 μg/mL FITC-dextran. The pairs b and f, c and g, d and h each show the same embryo at different stages (stage 22, a-d; stage 30, e-h). Control
embryos (a,e) were co-injected with 1× Yamamoto’s and FITC-dextran. Pictures of embryos with a fluorescent signal were taken at the indicated stages.
Classification was performed after the onset of eye pigmentation, according to the size of the eye: (b,f) weak, slightly reduced size; (c,g) moderate, severe size
reduction; (d,h) strong, eye-less. Embryos at stage 16 (i-k, n-o) are shown in dorsal view, anterior to the top; except for (l,p) which are at stage 17 and shown in
lateral view. For genotypic analysis (i-p), whole mount in situ hybridization experiments were performed on MO injected embryos and un-injected wild type
controls at stage 16 using digoxigenin-labelled RNA probes against pax6 (i,m), pax2 (j,n), gbx1 (k,o), and wnt1 (l,p) at stage 17. (i-k,m-o) Broken lines indicate
the outlines of the prospective neural domain estimated from the merged expression patterns formed by pax6, pax2 and gbx1 in wild type embryos (i-k). An
anterior shift of the expression domains was observed for all four genes. (l,p; arrowhead) wnt1 expression in the mid-hindbrain boundary. Scale bars 100 μm; a,
a-h; i, i-k andm-o; l, l and p. Abbreviations: MO, morpholino oligonucleotide
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improvement, which was also observed at higher concen-
trations. At 900 μM (450 μM each) 74% of the embryos
showed tcf3-specific phenotypes without toxic side effects
(those first appeared at 1200 μM).
We then tested lysine-phosphonic-ester (lpe) side
chains as a novel backbone modification of the PNAs
(Fig. 2a). A mixed 16mer PNA with the same target se-
quence as Tcf3PNA was synthesized (Tcf3kPNA; Fig. 2b).
Injection of these new PNAs resulted in identical tcf3
specific phenotypes, but in considerably higher numbers
(Fig. 4b and Additional file 1). At 100 μM the Tcf3kPNA
produced 76% tcf3 specific phenotypes, compared to 22%
for the Tcf3PNA. Similar improvements were also seen for
other concentrations. A peak level of 92% phenotypes was
observed at 400 μM with the first toxic effects of these
modified PNAs appearing at 600 μM. Therefore, the lpe-
side chain modification strongly improved the antisense
efficiency of PNAs. To test specificity, a two nucleotide
substitution was introduced (GT to TG at positions 8 and
9 of the PNA; Tcf3kPNAmut Fig. 2b). This substitution
resulted in a dramatic loss of the tcf3 knockdown pheno-
types (Fig. 4b and Additional file 1). At 100 μM none of
the embryos showed tcf3-specific phenotypes and at
600 μM only 11% did (compared to 93% for the non-
mutated version). Therefore, a highly specific antisense
function of the K-modified PNAs in an in vivo environ-
ment could be observed at low concentrations, directly
comparable to the results for morpholino oligonucleo-
tides. Taken together, the repeated appearance of the same
phenotypes with various different antisense molecules
clearly demonstrated specificity of the tcf3 knockdown
experiments.
Tcf3 function in eye development is mediated by
Groucho/Tle interaction
In order to understand the effect of Tcf3 misexpression
during embryogenesis, we injected a heat-inducible tcf3
construct into the blastomere of one-cell stage wild-type
embryos. The heat-inducible promoter allowed us a stage-
dependent gain-of-function analysis [28]. We first per-
formed heat treatment at mid-gastrulation (stage 14/15)
and analyzed the injected embryos after the onset of eye
pigmentation at stage 30. In this context, 31% (n = 27) of
the injected embryos showed reduced eye size and 8%
lacked eyes; neither varying DNA concentration nor heat-
induction time altered the eye phenotypes. Hence, based
on our results gain-of-function and loss-of-function ex-
periments for tcf3 resulted in similar phenotypes.
We subsequently focused on the functional domains of
Tcf3 which mediate transcriptional repression. More pre-
cisely, the Tcf3 protein contains two repression domains: a
CtBP interaction domain at the C-terminus [29] and a
Groucho/Tle interaction domain at the N-terminus [24]
(Fig. 5a). We therefore constructed differently truncated
tcf3 cDNAs that either lack the CtBP interaction domain
(Tcf3 (1-434)), or both the CtBP and the Groucho/Tle
interaction domain (Tcf3 (1-434)ΔGro). Injection of Tcf3
(1-434) cDNA lacking the CtBP binding site, increased the
frequency of embryos showing eye phenotypes to 26%
(Fig. 5f) compared to 8% for the full-length Tcf3 construct.
This indicates that CtBP interaction does not increase eye
phenotypes, but instead reduces them. On the other hand,
injection of the truncated tcf3 cDNA lacking both the
CtBP- and Groucho/Tle interaction domains (Tcf3
(1-434)ΔGro), resulted in a significantly reduced fre-
quency of embryos with strong eye phenotypes (5%),
which suggests that the Groucho/Tle interaction of Tcf3 is
more important for eye development than that with CtBP is.
Additionally, we examined the expression of the
retina-specific homeobox gene rx2 in the injected
embryos an early stage of eye development [30, 31]. In
agreement with the eye phenotypes, three different
A
B
Fig. 4 Knockdown efficiencies using modified PNAs. Quantitative
evaluation of tcf3 knockdown experiments. Results for injection of
the indicated antisense molecules at the indicated concentrations.
The blue bars represent the percentage of embryos with
phenotypes among the surviving embryos, the red bars represents
the mortality rate (see also Additional file 1)
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expression patterns of rx2 were observed in tcf3-injected
embryos at stage 21 (Fig. 5b-e). We compared the
expression pattern of rx2 in embryos injected either with
Tcf3 (1-434) lacking the CtBP binding site or Tcf3
(1-434)ΔGro lacking both the CtBP and the Groucho/
Tle interaction domains. The expression of rx2 was less
reduced in embryos injected with the Tcf3 construct that
lacks the Groucho/Tle interaction domain but still re-
tains the DNA binding- and the ß-catenin interaction
domains (Fig. 5f and Additional file 2). In particular, mis-
expressing this truncated version significantly reduced the
appearance of eye phenotypes up to 50% in the injected
embryos. Our data therefore suggest that Groucho/Tle
co-repressor proteins make a crucial contribution to eye
development. Moreover, in addition to eye phenotypes,
21% (n = 66) of Tcf3(1-434)ΔGro injected embryos
exhibited ectopic otic vesicles (Additional file 2B,C). We
observed ectopic otic vesicles in the trunk and tail regions
A
B
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Fig. 5 tcf3 gain of function phenotypes. a Schematic representation of full length Tcf3, Tcf3 lacking the CtBP binding site (Tcf3[1-434]), and a C-terminally
truncated Tcf3 lacking the Groucho/Tle interaction domain (Tcf3[1-434]ΔGro). b-f Embryos at the 1-cell stage were injected with either heat-inducible truncated
Tcf3 (Gfp:HSE:Tcf3(1-434); 40 ng/μl) or Tcf3 lacking the Groucho/Tle interaction domain (Gfp:HSE:Tcf3[1-434]ΔGro; 40 ng/μl). Heat induction was performed at
stage 14-15. Gfp positive embryos were selected at stage 22 for subsequent whole mount in situ hybridization experiments using digoxigenin-labelled RNA
probes against rx2 (c-f). b-e Flat mounts are shown in dorsal view, anterior at the top. Phenotypes were categorized according to their eye size and the
expression intensity compared to the control: (c) weak, small eyes, normal expression intensity; (d) small eyes, weak expression; (e), missing eyes and expression.
b Heat treated wild type control. f Quantitative results of the injections using rx2 in situ hybridization. Scale bar 100 μm
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of the developing embryos, hence, posterior to the en-
dogenous vesicles (Additional file 2C). Taken together, our
results suggest that Tcf3 function in eye development is
modulated by the Groucho/Tle corepressor interaction.
Two Groucho/Tle genes, tle1 and tle2b, have redundant
functions in eye development
Groucho/Tle co-repressor proteins have been implicated
in eye development [32, 33]. Particularly Tle1 and Aes
were shown to interact with the transcription factors
Six3 and Six6 during early eye development [33]. How-
ever, several groucho/tle genes are broadly expressed in
various developing tissues [34]. Thus, in order to inter-
fere with the function of all Groucho/Tle proteins within
one experiment we selected a dominant negative strategy
and used a truncated form of Tle4 that contains only the
Q domain. The Tle-Q domain is sufficient for inter-
action with Lef/Tcf proteins and forms a tetrameter
upon binding to Lef1 [22]. The Aes protein, which is a
truncated member of the Groucho/Tle family, contains
only the N-terminal Q and GP domains (Fig. 6a). It has
been used repeatedly as a dominant negative form for
Groucho/Tle proteins [24, 35] forming intra- as well as
intermolecular interactions with other Groucho/Tle pro-
teins via its Q-domain. The resulting tetramers therefore
will partially lack the C-terminal domains, which are not
present in the Aes protein. Most important at the
C-terminus are the domains of WD40 repeats which
represent a major protein-protein interaction domain.
Inefficient complex formation is therefore the conse-
quence of Aes expression. However, a major criticism of
this strategy is that important interactions also originate
from the Q-domain. Compared to other Groucho/Tle
family members, the Aes Q-domain shows a number of
deviations in its amino acid sequence. It is therefore not
clear how efficiently the Aes Q-domain can contribute
to the interactions in a mixed protein complex. To
address this issue, we tested the effect of Aes overex-
pression on an established Q-domain interaction. For
this we selected the Tle-Six3 interaction, which has been
shown to be critical for eye development [33], and
performed mammalian two-hybrid experiments. Our
results showed a stepwise reduction of both Tle1- and
Tle4-Six3 complex formation upon increasing Aes
concentrations, whereas a control interaction was not
affected (Additional file 3). This indicates that Aes overex-
pression can interfere with both N- and C-terminal inter-
actions of Groucho/Tle proteins in the mixed complexes.
Based on these data we generated two heat-inducible
transgenic lines for misexpression of Aes (HSE:Aes) and
the Tle4-Q domain (HSE:Q). We then performed heat
shock at mid gastrula stage and analysed the embryos
over the following days (Fig. 6b-e). In agreement with
previous studies we observed eye phenotypes [32, 33].
Interestingly in both transgenic lines a range of pheno-
types appeared which might be explained by variations
of the heat shock induction and the dependence of the
dominant negative approach on the resulting expression
levels. We used a phenotype classification scheme simi-
lar to the previous one. Embryos with a weak phenotype
developed slightly smaller eyes which point towards the
midline (Fig. 6c-c”), whereas embryos with a strong
phenotype showed cyclopic eyes (Fig. 6e-e”). As a mod-
erate phenotype we considered embryos between these
extremes (Fig. 6d-d”). Here, additionally to the weak
phenotype, the lenses were shifted anteriorly and mild
cyclopia anterior of the forebrain was observed. In
HSE:Aes embryos a total of 24% developed a phenotype
(n = 97), equally distributed between weak and strong.
The HSE:Q line showed a total of 34% phenotypes
among the induced embryos (n = 79), however, only 5%
of the embryos were categorized as having a strong
phenotype. Therefore, the interference of the Q-domain
was less efficient compared to the aes-misexpressing
line, but interestingly the phenotypes were identical. We
then analysed the expression pattern of marker genes for
retina (rx2), telencephalon (bf1) and midbrain (wnt1)
development in the transgenic embryos at stage 21
(Fig. 6f-k). Supporting the eye phenotypes, the
expression of rx2 was present but restricted to eye
size (Fig. 6i). In embryos with a strong phenotype, an
additional faint stripe of rx2 expression that con-
nected the two optic vesicles was observed in the
forebrain. In those embryos the expression of bf1 was
also impaired (Fig. 6j). Furthermore, the expression of
wnt1 indicated a slight reduction in the size of the
midbrain (Fig. 6k).
In order to elucidate which of the groucho/tle genes
are involved in eye development we specifically impaired
the function of individual genes using antisense oligonu-
cleotides. In medaka, six full length members of the
groucho/tle family were described; most of them are
expressed in largely overlapping domains indicating that
they might have redundant functions [34]. We selected
three groucho/tle paralogs (tle1, tle2b and tle3b) that are
specifically expressed in the optic placode [33, 34].
Interestingly, we observed similar eye phenotypes for all
three genes. According to our phenotype classification
10%-16% of the morphants showed eye defects (for more
details see Additional file 4), in which the tle2b-mor-
phants showed the highest frequencies in strong- (16%,
n = 237) and eye-less (7%) phenotypes. We next tested
combined inactivation and observed an additive effect in
tle1-tle2b morphants (27%, n = 44) but not in triple
morphants (17%, n = 58). The appearance of eye defects
in tle morphants fully supported our transgenic HSE:aes
and HSE:Q results. Nevertheless, we observed some
slightly different phenotypes resulting from these two
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approaches, in particular the cyclopic eye connection
in the tle1 morphants appeared in the middle of the
eyes (see Additional file 4C), whereas these connec-
tions were preferentially observed anterior to the
forebrain in the transgenic HSE:Aes and HSE:Q em-
bryos (Fig. 6d”).
Discussion
Knockdown of the tcf3 gene in medaka resembles the
zebrafish hdl/tcf3b double morphants
The expression and function of tcf3 in medaka is poorly
understood. In contrast to zebrafish, medaka has only a
single tcf3 gene (this study and [27]), however the
expression pattern closely resembled that of the zebra-
fish hdl and tcf3b genes (Fig. 1; [19, 20]). It was therefore
not surprising that the phenotype of medaka tcf3 mor-
phants resembled the combined inactivation of both
zebrafish tcf3 paralogs (e.g. complete lack of eyes and
anterior brain defects). Knockdown of medaka tcf3
resulted either in weakly or moderately affected embryos
with reduced eye size, covering the range of phenotypes
that have been seen for inactivation of single tcf3 genes
in zebrafish, or in strongly affected eye-less embryos
corresponding to the complete absence of Tcf3 proteins
in zebrafish hdl/tcf3b double morphants (Fig. 3). The
analysis of marker gene expression in the tcf3 morphants
verifies the strong effect on the Tcf3/Wnt gradient along
the AP axis [36, 37], all marker genes tested in this study
showed an anterior shift centering on the position of the
prechordal plate. These anterior defects are also in good
agreement with the AP defects seen in Wnt1 overex-
pression experiments [38]. Dorsky and colleagues ana-
lyzed the expression of these genes in zebrafish upon
tcf3 inactivation. Hdl mutants showed a decrease in
pax6 expression in the presumptive head region and
pax2.1 expression was expanded rostrally, whereas the
gbx1 domain remained unchanged. However, if both hdl
and tcf3b were inactivated, gbx1 also expanded anteri-
orly, thereby including the expression domain of pax2.1,
and the anterior expression of pax6 was completely lost
[20]. This stepwise reduction of Tcf3 activity in zebrafish
resulted in a progressive anterior shift of the marker
genes centring on the position of the prechordal plate
[36]. Taken together, a single tcf3 gene in medaka
combines the function of the two tcf3 paralogous genes
in zebrafish.
Novel side chains provide higher antisense efficiency for
PNAs
In this study, we also applied PNAs for tcf3 knock-
down experiments in medaka embryos. We used
phosphonic ester modified mixed PNAs, which previ-
ously were shown to be suitable for loss-of-function
experiments in medaka [9]. Here again we could
demonstrate a specific knockdown of gene function.
Initially we used pePNAs with two TML end groups
and obtained almost 60% specific phenotypes (400 to
900 μM) (Fig. 4a and Additional file 1). At higher
concentrations this percentage further increased,
however, also unspecific toxicity was observed. The
pePNA molecules were also effective in a splice-
blocking approach. Although the efficiency was lower
compared to the translational blocking experiments,
the same tcf3 specific phenotypes appeared (Fig. 4a
and Additional file 1). Furthermore, a combined injec-
tion of both PNAs synergistically improved the overall
efficiency of the antisense molecules (74% specific
phenotypes).
Morpholino oligonucleotides resulted in higher effi-
ciency when directly compared with pePNAs (e.g. 92%
and 22% phenotypes at 100 μM, respectively). However,
also toxic effects started at considerably lower concen-
trations (200 μM and 1200 μM, respectively). Otherwise,
the obtained phenotypes were identical for the two
antisense molecules (Fig. 4b and Additional file 1).
Interestingly, further modification of the PNA backbone
with lpe-side chains (Fig. 2a) considerably improved the
PNA efficiency (Fig. 4b and Additional file 1). At con-
centrations of 50 μM to 400 μM, 63% to 92% of the em-
bryos showed tcf3 specific phenotypes (with toxicity first
appearing at 600 μM). This efficiency is in the same
range as that for the morpholino oligonucleotides. An
exchange of 2 nucleotides in this sequence (GT to TG at
positions 8 and 9) resulted in a dramatic drop in pheno-
types (8% to 16% phenotypes at 100 μM to 400 μM),
thus demonstrating the high specificity of this 16mer
PNA. Therefore, novel side chain modifications effi-
ciently improved the in vivo antisense function of PNAs.
(See figure on previous page.)
Fig. 6 Aes-mediated Groucho/Tle loss of function phenotypes. a Schematized presentation of full length Tle protein, the Q-domain, and Aes. For transgenic
lines, embryos at the 1-cell stage were injected with 20 ng/μl of DNA (Gfp:HSE:Aes and Gfp:HSE:Q). The F1 generation was heat-induced (10 min, 43.5 °C) at
stage 15/16. b-k Embryos are shown in dorsal view, anterior to the top. f-k Flat mounts. c-d Phenotypes of the Aes/Q-mediated Groucho/Tle loss of function
were categorized according to their eye phenotype into: (c-c″) weak, smaller eyes tilted towards the midline; (d-d”) moderate, beginning cyclopia anterior;
strong (e-e”), cyclopic eye. For whole mount in situ hybridization experiments (f-k), using the indicated digoxigenin-labelled RNA probes, fixation was performed
at stage 21; heat treatment occurred as described before. i rx2 expression indicates a reduction in eye size, the eyes are tilted at the anterior end towards the
midline (arrowheads); (j) Bf1 expression is reduced; (k) Wnt1 expression indicates a reduction in midbrain size. Instead of a defined expression close to the
midline (h, arrows), Aes misexpression resulted in an indistinct expression pattern throughout the midbrain (K, arrows). (b-b″, f-h) control embryos were
heat-treated wild type embryos. Scale bars 100 μm; b, b-e”; f, f-k
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Groucho/Tle corepressor proteins are critical for Tcf3
function in eye development
The Tcf3 protein has two major co-repressor interaction
domains; an amino-terminally located domain that inter-
acts with Groucho/Tle proteins [24] and a carboxy-
terminal domain that interacts with the CtBP protein
[29]. Our results indicate that the CtBP interacting
domain in Tcf3 is dispensable for early embryonic eye
development; indicating that the interaction with
Groucho/Tle proteins is more crucial. In particular, Tcf3
variants lacking the Groucho/Tle interaction domain
showed considerably reduced numbers of eye pheno-
types in our gain-of-function experiments. These results
further support the idea that the Groucho/Tle co-repres-
sors are required for eye development [33, 39].
To interfere with the function of all Groucho/Tle
proteins we used three strategies. Firstly, we misex-
pressed the aes gene. Aes (Fig. 6) is a naturally occurring
truncated family member of full-length Groucho/Tle
proteins that consists of only the Q and the GP domains
[25, 26, 40]. The Q domain allows Aes to oligomerize
with full-length Groucho/Tle proteins, thereby redu-
cing the number of C-terminal interaction domains
[21, 33, 41–45]. The GP domain, however, is func-
tionally different from full-length Groucho/Tle
proteins since it does not interact with HDAC co-
repressors [13, 39, 46, 47]. It was therefore suggested
that through this interaction Aes turns Groucho/Tle olig-
omers into non-functional complexes, which therefore
have a reduced number of C-terminal WD-40 interaction
domains and a reduced efficiency to cooperate with
HDAC co-repressors [21, 41, 42, 44, 48, 49]. Supportive of
this hypothesis, our mammalian two-hybrid experiments
using the Six3 transcription factor, indicated that addition-
ally N-terminal interactions with the Q-domain are
blocked by Aes misexpression. Indeed, ectopic expression
of Aes in medaka resulted in considerably smaller eyes
and otic vesicles and reduced expression of optic and otic
marker genes, suggesting an efficient block of Groucho/
Tle activity [32, 33]. In addition to the Groucho/Tle block-
ing functions, Aes is also known to exhibit specific func-
tions on its own in certain cellular contexts [46, 50, 51].
The observed phenotypes could therefore be a mixture
between groucho/tle loss-of-function and aes gain-of-
function effects. Secondly, we misexpressed the Tle4
Q-domain and could phenocopy the Aes misexpression
embryos, however, at a lower efficiency. The reduction of
the bf1 and wnt1 expression field in the forebrain and
midbrain in those embryos also confirmed the observed
phenotypes and is in agreement with a previous study in
Xenopus [52]. Finally, we analysed the function of grou-
cho/tle genes by injection of morpholino oligonucleotides.
Previously, we have shown that three paralogs of medaka
groucho/tle genes (tle1, tle2b and tle3b) are expressed
during early eye development [34]. Interestingly, knock-
down of each of these genes, individually or in combin-
ation, resulted in specific impairment of eye development
which suggests redundancy. These phenotypes closely re-
sembled those of the dominant negative experiments and
thus fully support this approach.
In addition to eye phenotypes, we also observed ec-
topic otic vesicles in the Tcf3[1-434]ΔGro- injected em-
bryos. The appearance of ectopic otic vesicles might be
caused by a dominant negative effect of the overex-
pressed truncated Tcf3, thus blocking the repressing
function of full-length Tcf3. Such an anti-repressive ef-
fect would be equivalent to ectopic Wnt activation.
Indeed, we have previously shown that induction of
Wnt signaling leads to the formation of ectopic otic
vesicles [38, 53].
Conclusion
Taken together, our results suggest that a single tcf3
gene in medaka is crucial for eye development and its
function is modulated by interaction with Groucho/Tle
co-repressor proteins. Gain-of-function analyses of Aes
and the Q-domain, as dominant negative effectors, to-
gether with the loss-of-function analyses of individual tle
genes confirm this interpretation. Moreover, our results
indicate that three tle genes (tle1, tle2b and tle3b) might
have redundant functions during eye development.
Methods
PNA and morpholino oligonucleotide synthesis
Lysine-phosphonic-ester Ugi-PNA monomers were syn-
thesized according to the following process. First, an
N-Cbz or N-Boc protected phosphono glycinate was
reacted with the appropriate aldehyde in a Horner-
Wadsworth-Emmons [54–56] followed by enantioselec-
tive hydrogenation using Burk’s catalyst [57–59] to give
the α-substituted protected glycinate. Deprotection of
the α-amino function and subsequent reductive amina-
tion with N-Boc-amino acetaldehyde gave the Ugi-PNA-
monomer backbone. The latter was coupled to the
appropriate protected nucleobase acetic acid component,
employing HATU as coupling reagent. Finally, deprotec-
tion of the carboxylic function yielded the Ugi PNA
monomer. Synthesis of the C3-phosphonic-ester-Ugi-
PNA monomer building blocks was performed as
described previously [9]. The PNAs were dissolved to
1 mM in nuclease free water by repeated shaking and
vortexting. Finally they were gently sonicated for 2 min
with repeated pulses. Subsequently the PNAs were
kept at −80 °C. Phosphorodiamidate morpholino oli-
gonucleotides (abbreviated here as morpholinos) were
manufactured by Gene Tools (see Fig. 3). Morpholino
sequences for the tle genes in 5′-3′ direction: tle1,
CGCGTCTTGTCCTGAAACCCCGCTA; tle2b, GGCA
Doenz et al. BMC Biotechnology  (2018) 18:1 Page 11 of 14
GTGCGTCCTCGTGGCTCTTTC; tle3b, CGGCCTT
GTGGATACATGTCTCGTC. For injection into me-
daka embryos, morpholinos were dissolved in 1×
Yamamoto’s Ringer solution at the indicated concen-
tration and injected into the blastomere at the one-
cell stage.
DNA constructs
All DNA constructs for microinjection were under the
control of a bi-directional heat-inducible promoter [28]
and contained either the mouse Aes/Grg5 cDNA, the
mouse Tle4 Q domain (AA 1-135), or various deletion
fragments of Tcf3 cDNA (see Fig. 5 for details). For cell
culture experiments pMC [60] and pKC (polylinker
modification of pKW) [61] were used (both vectors con-
tain cytomegalovirus promoters). pLucF24ZF; luciferase
reporter under the control of a Fos minimal promoter
and ZFHD binding sites. pMChSix3(85-203)mZFb6; the
human Six3 fragment (positions of amino acids in
brackets) fused to a ZFHD DNA binding domain [62]
and the “base” leucine-zipper [63]. pMCTle1VP16 and
pMCTle4VP16; human Tle1 and mouse Tle4 were fused
to the transcriptional activation domain of the herpes
simplex virus protein VP16, respectively. pMCacidVP16
contains the “acid” leucine-zipper fused to VP16,
pKCAes the mouse Aes/Grg5 cDNA.
Microinjection into medaka embryos
Embryos of the medaka Cab strain were used for all ex-
periments. Adult fish were maintained at 26 °C with an
artificial 14 h light and 10 h dark cycle. Stages were
determined according to the morphological markers
described in Iwamatsu [64]. DNA constructs were co-
injected with I-SceI meganuclease enzyme (0.5 U/μl) at
the one-cell stage. For transient studies, different ver-
sions of truncated tcf3 cDNAs (HSE:tcf3 constructs)
were injected at a concentration of 40 ng/μl. For the
generation of a heat-inducible aes (HSE:aes) and Q-
domain (HSE:Q) transgenic lines, DNA constructs were
injected at 10 ng/μl concentration together with I-SceI
meganuclease enzyme. The embryos were incubated at
normal conditions (1× ERM buffer at 27 °C). Heat
treatment was performed at stage 14 (except if otherwise
indicated) for 10 min at 43.5 °C. For co-injection experi-
ments FITC-dextran (FD10S, Sigma-Aldrich) was used.
Whole-mount in situ hybridization
Whole-mount in situ hybridization using DIG-labelled
RNA probes was performed as described previously [34].
Probes against tcf3 (Ensembl: ENSORLT00000014810)
and gbx1 (Ensembl: ENSORLT00000021915) were PCR
amplified from medaka embryonic cDNA using specific
primers for tcf3 (5’-CGGATCCATGGCTCAACTGAAC
GGAGGC-3′ and 5’-CGAAGACGGCTGGACATGGAT
GCATTCA-3′) and gbx1 (5’-TTAGAAAATACAGCCAC
AA-3′ and 5’-TCACTGTAAAAAGTACCTG-3′). The
expression patterns of pax6 [65], pax2 [66], wnt1 [67],
rx2 [30] and bf1 [68] were described previously.
Cell culture and mammalian two-hybrid assay
HeLa cells (300,194, Cell Line Services) were transfected
in polyethylenimine (2.5 μg/ml) coated 96-well plates
[69] using TurboFect transfection reagent according to
the instructions of the manufacturer (Thermo Scientific).
For luciferase activity detection, additional transfection
of 2 ng Gaussia luciferase expression vector pMCGlucS
served as an internal reference. Luciferase activities were
measured 24 h after transfection. For the mammalian
two-hybrid assay, cells were co-transfected with 70 ng of
firefly luciferase reporter construct pLucF24ZF, 20 ng of
Six3 expressing plasmid pMChSix3(85-203)mZFbase
(six-domain of human Six3), 0-6 ng of Aes expressing
plasmid pKCAes, and 20 ng of either pMCTle1VP16,
Tle4 pMCTle4VP16 or the control pMCacidVP16.
Additional file
Additional file 1: Overview of the PNA and MO induced loss of function
phenotypes. Embryos at the 1-cell stage were injected with PNAs or MOs at
the indicated concentrations. Phenotypes were categorized according to
the size of the eyes into: weak, slightly smaller eyes; moderate, smaller eyes;
strong, eye-less. Abbreviations: PNA, peptide nucleic acid; MO, morpholino
oligonucleotides. (PDF 10028 kb)
Additional file 2: Gro/Tle dependence of 1 tcf3 in gain-of-function
experiments. Embryos at the 1-2 cell stage were co-injected with
40 ng/μl of the indicated gfp:HSE:Tcf3 constructs. Heat treatment
(10 min, 43.5 °C) was applied at stage 14. (A) Statistical overview of the
phenotype distribution. Whole mount in situ hybridization experiments
for rx2 were performed on embryos at stage 21. (B) dorsal view of a stage
31 embryo with anterior at the top, (C) lateral view with anterior at the
left. Arrowheads indicate ectopic otic vesicles, the arrow points to the
endogenous otic vesicle. Scale bar 100 μm; B and C. (PDF 10028 kb)
Additional file 3: Mammalian two-hybrid analysis of Aes-mediated Gro/
Tle repression. 20 ng of the expression constructs (pMCamVP16,
pMCTle4VP16 or pMCTle1VP16) were co-transfected with 70 ng of firefly
luciferase reporter construct pLucF24ZF, 20 ng of the expression
construct for the six-domain of human Six3 (pMChSix3(85-203)mZFb6)
and full length Aes (pKCAes at the indicated concentrations) into HeLa
cells. The interaction of the artificial leucine zipper domain “acid” and
“base” [63] was used as a control. All three interactions were set 100% in
the absence of Aes (acid/base corresponds to a more than 100 fold
activation of the luc reporter construct compared to a control without
bait, similar induction rates were seen for Tle4/Six3 and Tle1/Six3).
Addition of the Aes expression construct at the indicated concentrations
did not affect the acid/base interaction (blue bars), but strongly reduced
the Tle4/Six3- (red bars) and the Tle1/Six3 interaction (green bars).
(PDF 10028 kb)
Additional file 4: MO-induced gro/tle loss of function phenotypes.
Embryos at the 1-cell stage were co-injected with morpholino oligonucleotides
and 1 μg/ml FITC-dextran. Injections were performed using either a single
morpholino directed against tle1 (C), tle2b (D,F), and tle3b (E), or combinations
directed against tle1 + 2b (H), tle1 + 3b (I), tle2b + 3b (J), and tle1 + 2b + 3b (K).
Single morpholino oligonucleotides were injected at a concentration of 600 μM
(C-F) and combinatorial injections (H-K) were performed using 300 μM of each
MO. Phenotypes of FITC-dextran positive embryos were observed after the
beginning of eye pigmentation at stage 32 (B-F) and stage 28 (G-K). (B,G) Wild
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type control embryos were injected with 1× Yamamoto’s and FITC-dextran. All
embryos are shown in dorsal view with anterior at the top. Compared to the
wild type controls (B,G), morpholino injected embryos developed smaller eyes
that were shifted towards the midline (D,E,J,K) or cyclopic eyes (C,H,I). In rare
cases the eyes were lost entirely (E). (A) Phenotypes of FITC-positive embryos
were categorized at stage 28-32 into weak and strong phenotypes. Weak pheno-
types developed smaller eyes that were shifted towards the midline, whereas
strong phenotypes showed cyclopic eyes. Eye-less phenotypes were included
into the group of strong phenotypes. Abbreviations: MO, morpholino oligo-
nucleotide; WT, wild type. Scale bar 100 μM. (PDF 10028 kb)
Abbreviations
aegPNA: N-[2-aminoethyl]-glycine PNA; AP: Anterior-posterior; lpe: Lysine-
phosphonic-ester; MHB: Mid-hindbrain boundary; MO: Morpholino
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